Allogeneic tumor-specific cytotoxic T lymphocytes
- 1 September 1992
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 34 (5) , 349-354
- https://doi.org/10.1007/bf01741557
Abstract
We report the development of cytotoxic T lymphocytes specific for an allogeneic brain tumor in a rat model. DA strain cytotoxic T cell precursors stimulated by an allogeneic tumor (9L gliosarcoma) from the Fischer rat could generate a population of cytotoxic T lymphocytes that lysed the allogeneic 9L tumor but failed to lyse other targets, including Fischer concanavalin-A(ConA)-stimulated lymphoid blast targets. DA T cells depleted of reactivity to the Fischer haplotype (DA-f) retained reactivity to the 9L tumor, demonstrating that T cell precursors with specificity for normal Fischer alloantigens were not required for the generation of a response to the 9L Fischer tumor. The preferential lysis of the tumor target did not simply reflect a higher density of Fischer target antigens on the tumor than that found on normal Fischer ConA blast targets. First, the relative densities of class I antigen on the 9L tumor and normal Fischer ConA blasts were comparable. Second, cytotoxic T cells could not be generated from DA-f precursors when Fischer ConA blasts were used as stimulators. If DA-f T cells were simply responding to the higher density of Fischer antigen found on 9L tumor, it would have been expected that the ConA blasts expressing comparable levels of antigen to that found on the tumor would have generated cytotoxicity for both the 9L and ConA targets. We conclude that the cytotoxic T cells are specific for a determinant expressed only by the tumor. Such tumor-specific cytotoxic T cells could be useful in vivo for adoptive immunotherapy of brain tumors.Keywords
This publication has 34 references indexed in Scilit:
- Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapyNeurosurgery, 1991
- Immunology of Transplantation in the Central Nervous SylftemStereotactic and Functional Neurosurgery, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Induction of cytotoxic T cell precursors in vivo. Role of T helper cells.The Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Natural Killer Cells Do Not Belong to the Recirculating Lymphocyte PopulationScandinavian Journal of Immunology, 1982
- Different rules govern help for cytotoxic T cells and B cellsNature, 1978
- The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.The Journal of Experimental Medicine, 1977
- T cells mediate transplantation toleranceNature, 1975
- THE FATE OF PARENTAL STRAIN SMALL LYMPHOCYTES IN F1 HYBRID RATSAnnals of the New York Academy of Sciences, 1962